logo

For the Inventor, By the Inventor

Newton, MA, United States of America

Patricia A D'Amore

This inventor holds 6 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignees: The Schepens Eye Research Institute, Inc., Massachusetts Eye and Ear Infirmary. Active years: 2016-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Patricia A D'Amore. Retrieved from https://idiyas.com/inventor/patricia-a-d-amore

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 6(Granted Patents)


Location History:

  • Boston, MA (US) (2021)
  • Newton, MA (US) (2016 - 2023)

Company Filing History:

goldMedal6 out of 133 
 
The Schepens Eye Research Institute, Inc.
 patents
silverMedal1 out of 276 
 
Massachusetts Eye and Ear Infirmary
 patents
where one patent can have more than one assignee

Years Active: 2016-2023

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents
1. 11680266 - Endomucin inhibitor as an anti-angiogenic agent (2023-06-20),
2. 11260048 - Compounds and compositions for inhibiting retinal pigment epithelium degeneration and methods using the same (2022-03-01),
3. 11229662 - Compositions and methods for the treatment of aberrant angiogenesis (2022-01-25),
4. 10906969 - Local orbital therapy for thyroid eye disease (2021-02-02),
5. 10883108 - Endomucin inhibitor as an anti-angiogenic agent (2021-01-05),
6. 9365627 - Endomucin as an anti-inflammatory agent (2016-06-14),

Title: Patricia A D'Amore: Innovator in Ocular Research

Introduction

Patricia A D'Amore is a prominent inventor based in Newton, MA, known for her significant contributions to ocular research. With a total of six patents to her name, she has made remarkable strides in the field of ophthalmology, particularly in understanding and treating conditions related to retinal degeneration.

Latest Patents

Among her latest patents is the invention titled "Endomucin inhibitor as an anti-angiogenic agent." This method focuses on reducing neovascularization in ocular tissue by utilizing an inhibitor of endomucin expression or activity. Another notable patent is "Compounds and compositions for inhibiting retinal pigment epithelium degeneration and methods using the same." This invention provides compounds capable of inhibiting retinal pigment epithelium degeneration or geographic atrophy associated with age-related macular degeneration.

Career Highlights

Patricia has worked with esteemed organizations such as the Schepens Eye Research Institute and Massachusetts Eye and Ear Infirmary. Her work in these institutions has been pivotal in advancing research and developing innovative solutions for ocular diseases.

Collaborations

Throughout her career, Patricia has collaborated with notable colleagues, including Magali Saint-Geniez and Cindy Park-Windhol. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.

Conclusion

Patricia A D'Amore's contributions to ocular research through her patents and collaborations highlight her dedication to improving eye health. Her innovative work continues to impact the field significantly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…